Windtree Therapeutics Inc (NASDAQ: WINT) kicked off on Tuesday, down -22.68% from the previous trading day, before settling in for the closing price of $2.91. Over the past 52 weeks, WINT has traded in a range of $2.90-$737.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -25.00% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 94.00%. With a float of $0.75 million, this company’s outstanding shares have now reached $0.75 million.
In an organization with 15 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Windtree Therapeutics Inc (WINT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Windtree Therapeutics Inc is 0.42%, while institutional ownership is 0.84%. The most recent insider transaction that took place on Oct 08 ’24, was worth 4,942. In this transaction President and CEO of this company bought 5,431 shares at a rate of $0.91, taking the stock ownership to the 8,638 shares.
Windtree Therapeutics Inc (WINT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 94.00% per share during the next fiscal year.
Windtree Therapeutics Inc (NASDAQ: WINT) Trading Performance Indicators
Take a look at Windtree Therapeutics Inc’s (WINT) current performance indicators. Last quarter, stock had a quick ratio of 0.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -931.66, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -143.00 in one year’s time.
Technical Analysis of Windtree Therapeutics Inc (WINT)
Let’s dig in a bit further. During the last 5-days, its volume was 2.0 million. That was better than the volume of 0.46 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 2.74%. Additionally, its Average True Range was 1.14.
During the past 100 days, Windtree Therapeutics Inc’s (WINT) raw stochastic average was set at 0.29%, which indicates a significant decrease from 1.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 110.01% in the past 14 days, which was lower than the 134.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.63, while its 200-day Moving Average is $135.85. However, in the short run, Windtree Therapeutics Inc’s stock first resistance to watch stands at $2.57. Second resistance stands at $2.90. The third major resistance level sits at $3.14. If the price goes on to break the first support level at $2.00, it is likely to go to the next support level at $1.76. Assuming the price breaks the second support level, the third support level stands at $1.43.
Windtree Therapeutics Inc (NASDAQ: WINT) Key Stats
The company with the Market Capitalisation of 1.58 million has total of 749K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -20,290 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -2,750 K.
